Daniel Gehrlach

Daniel Gehrlach is project manager for personalized depression therapy at HMNC Brain Health.

After obtaining degrees in Pharmaceutical Biotechnology in Biberach and Medical Neurosciences at the Charité in Berlin, he completed his PhD at the Max-Planck-Institute of Neurobiology in Martinsried. He gained valuable experience in preclinical and translational in-vivo models of affective disorders, in particular in the fields of anxiety, depression and addiction. Daniel was awarded the Max-Planck-Institute’s “Young Scientist Award 2019” for his doctoral project, which was also published in Nature Neuroscience.

In his role as project manager at HMNC Brain Health, he supports the design and conduct of clinical studies, as well as the development of companion diagnostics. Furthermore, he is involved in HMNC’s business development and intellectual property activities.